Loading clinical trials...
Loading clinical trials...
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
Conditions
Locations
1
United States
Stanford University School of Medicine
Stanford, California, United States
Start Date
September 1, 2009
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2012
Last Updated
April 9, 2020
NCT07445984
NCT01366612
NCT02158858
NCT05969821
NCT02766153
NCT04631211
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions